Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀڱðæºÎ ¼¼Æ÷Áø °Ë»ç ÀÌ»ó°ú ÀڱðæºÎ Á¾¾ç ¼Ò°ßÀ» º¸ÀΠȯÀÚ¿¡°Ô¼­ Á¦ÇÑÈ¿¼ÒÁú·®´ÙÇü¼º ºÐ¼®°ú DNA chipÀ» ÅëÇÑ ÀÎÀ¯µÎÁ¾ ¹ÙÀÌ·¯½º À¯ÀüÀÚÇü °Ë»çÀÇ À¯¿ë¼º ºñ±³ Comparison of Efficacy of Human Papilloma Virus Genotyping Assays using Restriction Fragment Mass Polymorphism and DNA Chip Analysis in Patients with Abnormal Pap Smear and Uterine Cervical Cancer

´ëÇѺ´¸®ÇÐȸÁö 2006³â 40±Ç 6È£ p.439 ~ 447
Á¤ÇöÀç, ±è¼º³², ÀÌÀºÈñ, Áö¹Ì¼±, ±è¹Î¾Æ, Ȳ¼±¿µ, Á¶ÈñÁ¤, ±è¼ö¿Á, È«¼±Ç¥,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤ÇöÀç ( Chung Hyun-Jae ) 
(ÁÖ)Áø¸ÅÆ®¸¯½º Áß¾Ó¿¬±¸¼Ò

±è¼º³² ( Kim Sung-Nam ) 
³ì½ÊÀÚÀÇ·áÀç´Ü Áø´Ü°Ë»çÀÇÇаú
ÀÌÀºÈñ ( Lee Eun-Hee ) 
³ì½ÊÀÚÀÇ·áÀç´Ü Áø´Ü°Ë»çÀÇÇаú
Áö¹Ì¼± ( Jee Mi-Sun ) 
³ì½ÊÀÚÀÇ·áÀç´Ü Áø´Ü°Ë»çÀÇÇаú
±è¹Î¾Æ ( Kim Min-A ) 
¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Ȳ¼±¿µ ( Hwang Sun-Young ) 
(ÁÖ)Áø¸ÅÆ®¸¯½º Áß¾Ó¿¬±¸¼Ò
Á¶ÈñÁ¤ ( Cho Hee-Jung ) 
(ÁÖ)Áø¸ÅÆ®¸¯½º Áß¾Ó¿¬±¸¼Ò
±è¼ö¿Á ( Kim Soo-Ok ) 
(ÁÖ)Áø¸ÅÆ®¸¯½º Áß¾Ó¿¬±¸¼Ò
È«¼±Ç¥ ( Hong Sun-Pyo ) 
(ÁÖ)Áø¸ÅÆ®¸¯½º Áß¾Ó¿¬±¸¼Ò

Abstract


Background: High-risk human papilloma virus (HPV) infection is the primary cause of cervical cancer; there is a need for more sensitive and reliable methods for HPV genotyping to use as screening tools for early detection and intervention.

Methods: A novel MALDI-TOF MS-based assay, termed Restriction Fragment Mass Polymorphism (RFMP) was developed for multiple HPV genotyping. Its performance was compared with DNA chip technology. The study was based on 164 cases classified as normal (n=40), ASCUS (n=53) and invasive squamous cell carcinoma (SCC, n=71) by a PAP smear and/or cervical colposcopic biopsy.

Results: High-risk genotypes were detected in 7.5%, 47.2% and 97.2% in normal, ASCUS and SCC groups by RFMP, and in 20.0%, 41.5% and 90.1% using DNA chip technology, respectively. The results showed substantial concordance, with a kappa coefficient of 0.688, between the methods. Diagnostic sensitivity and specificity for cervical cancer were found to be 97.2% and 92.2% with RFMP and 90.1% and 80.0% using DNA chip microarrays.

Conclusions: RFMP and DNA chip technologies were shown to be reliable methods for HPV genotyping with a high concordance. The improved sensitivity and specificity should make RFMP a viable option for the management of women with cervical neoplastic lesions.

Å°¿öµå

Human papillomavirus;Genotype;Matrix-assisted laser desorption-ionization mass spectrometry

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS